Bob Redman is a seasoned pharmaceutical professional with 20 years of experience in leadership roles, particularly in oncology sales and marketing. Currently serving on the Board of Directors at Tangram, Inc. since 2017, Bob held various positions at Eli Lilly and Company, culminating as Associate Vice President of Oncology Sales from 2022 to 2024. Bob also completed an Executive MBA at Duke University’s Fuqua School of Business between 2021 and 2023, following a Bachelor's degree in Marketing from Seton Hall University in 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices